Navigation Links
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
Date:1/31/2011

rust formed the UK's first Academic Health Science Centre. This unique partnership aims to improve the quality of life of patients and populations by taking new discoveries and translating them into new therapies as quickly as possible.

About Cancer Research UKCancer Research UK is the world's leading cancer charity dedicated to saving lives through research.

  • The charity's groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. This work is funded entirely by the public.
  • Cancer Research UK has been at the heart of the progress that has already seen survival rates double in the last forty years.
  • Cancer Research UK supports research into all aspects of cancer through the work of over 4,000 scientists, doctors and nurses.
  • Together with its partners and supporters, Cancer Research UK's vision is to beat cancer.

  • For further information about Cancer Research UK's work or to find out how to support the charity, please call 020 7121 6699 or visit www.cancerresearchuk.org

    About Leukaemia and Lymphoma ResearchLeukaemia and Lymphoma Research is the only national UK charity devoted exclusively to improving treatments, finding cures and learning how to prevent leukemia, Hodgkin's lymphoma and other lymphomas, myeloma and the related blood disorders. Leukaemia and Lymphoma Research receives no government grants and urgently needs to raise over 100 million pounds in the next five years to commit to new research. From basic laboratory research to clinical trials with patients, Leukaemia and Lymphoma Research is committed to saving lives by funding high quality, carefully selected research throughout the UK. Leukaemia and Lymphoma Research currently supports 30 Specialist Programmes in which the groups undertake long-term intensive research into relevant areas of leukemia and the rel
    '/>"/>

    SOURCE Inovio Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
    2. Surgeons at University of California San Diego Perform 1st TRAM Flap Procedure in an International Multi-Center Study Using TIGR® Matrix Surgical Mesh, the Worlds 1st Long-Term Resorbable Mesh
    3. EDC Functionality, Ease of Data Entry, and Access to Data All Factors in University of Virginia Cancer Centers Selection of the OnCore Clinical Research Management System
    4. Stereotaxis Announces Global Initial Training Site at University of Chicago
    5. SurgiCount Medical Announces the Successful Implementation of the Safety-Sponge® System at the University of Michigan Health System
    6. Pfizer Launches Global Centers for Therapeutic Innovation, a Network of Research Partnerships, With University of California, San Francisco
    7. The University of Tennessee Medical Center and ContinuumRx Form Healthcare Joint Venture
    8. D3 Radiation Oncology Solutions has Completed Collaborative Commissioning of Two Varian TrueBeam Medical Linear Accelerators at the John Theurer Cancer Center, Hackensack University Medical Center
    9. Novus Scientific and Singapore Association of Plastic Surgeons (SAPS) Host the Inaugural Event of SOFTISSUE - The Issue of Soft Tissue, Featuring James J. Chao, M.D., FACS, Professor of Plastic Surgery and Orthopedic Surgery, University of Califor
    10. Columbia University Students Learn About Pharmacy Benefit Management From Prime Therapeutics President and CEO
    11. Siemens Wins $25 Million Contract From Rush University Medical Center
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2015)...  Insulet Corporation (NASDAQ: PODD ), the leader ... Insulin Management System, today announced that Dr. ... of Directors. Dr. Hopfield brings more than ... Board. She currently serves as the Vice Chair of ... largest diabetes research center, diabetes clinic, and provider of ...
    (Date:7/28/2015)... 2015   Regulus Therapeutics Inc . ( NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... quarter ended June 30, 2015 on Tuesday, August 4, ... Regulus will host a conference call and webcast ... Daylight Time to discuss its second quarter 2015 financial ...
    (Date:7/28/2015)... Mass., July 28, 2015  Psychemedics Corporation (NASDAQ: ... the period ended June 30, 2015.  The Company also ... to shareholders of record as of August 7, 2015 ... be the Company,s 76 th consecutive quarterly dividend. ... June 30, 2015 was $7.0 million versus $7.7 million ...
    Breaking Medicine Technology:Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Psychemedics Corporation Announces Second Quarter Earnings 2Psychemedics Corporation Announces Second Quarter Earnings 3Psychemedics Corporation Announces Second Quarter Earnings 4Psychemedics Corporation Announces Second Quarter Earnings 5Psychemedics Corporation Announces Second Quarter Earnings 6Psychemedics Corporation Announces Second Quarter Earnings 7Psychemedics Corporation Announces Second Quarter Earnings 8
    ... Genmab Initiates a Phase I/II Study of Zalutumumab in ... Advanced Head and Neck Cancer., COPENHAGEN, June 24 ... a Phase I/II study of zalutumumab,(HuMax-EGFr(TM)) in combination with ... The study will include a maximum of 36,patients who ...
    ... Biopharmaceuticals Plc, a,biopharmaceutical company focused on the development ... initiated a Phase II,equivalent study of MRX-4, in ... allergic rhinitis (AR). The two-arm, randomized, multi-dose,double-blind, placebo-controlled ... study is expected to be completed by the ...
    Cached Medicine Technology:Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 2Genmab Initiates Study of Zalutumumab With Radiotherapy in Head and Neck Cancer 3Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis 2
    (Date:7/29/2015)... DC (PRWEB) , ... July 29, 2015 , ... ... aluminum-related illnesses is seeking funding for a study on the potentially lifesaving impact ... Research Institute today . , The research proposal is based on a ...
    (Date:7/29/2015)... ... , ... One may not expect to encounter a kickball game or the ... was happening on the campus of Piedmont Crossing , a local 60-acre retirement ... Only , a five-star childcare center which operates on the same campus. As many ...
    (Date:7/28/2015)... Falls Church, VA (PRWEB) , ... July 29, 2015 , ... ... **FDAnews Webinar**, Aug. 18, 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/productpipeline ... biotech, what they can — and can’t — say about it is tightly regulated ...
    (Date:7/28/2015)... , ... July 29, 2015 , ... The insurance telematics ... automakers. This would allow insurers to access the on-board vehicle data and better understand ... when it comes to sharing vehicle data. However times are changing and automakers realize ...
    (Date:7/28/2015)... ... 2015 , ... A skin cancer screening program offered by the American Society ... for “helping to make the world a better place.” , The Choose Skin Health ... Society of Association Executives. Power of A recognizes organizations annually that “distinguish themselves with ...
    Breaking Medicine News(10 mins):Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 2Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 3Health News:FDAnews Announces — Talking About Your Product Pipeline: How FDA and SEC Regulate Life Sciences Communications Webinar, Aug. 19, 2015 4Health News:General Motors Engaging Insurance Partners for the Connected Car 2Health News:General Motors Engaging Insurance Partners for the Connected Car 3Health News:ASDS Skin Cancer Program Honored 2Health News:ASDS Skin Cancer Program Honored 3
    ... may be increasing the drug resistance across the world., ... in the journal The Lancet, worldwide resistance to drugs ... 12% since the mid-nineties., ,Adamantanes have been used ... 30 years. Previous surveillance studies have identified a low ...
    ... companies, said Wednesday it had tied up with private ... over 100 cities. // , ,Under the agreement, ... 240 WebWorld cyber stores in 105 cities to offer ... access to the Apollo Telemedicine Networking Foundation (ATNF), said ...
    ... Institute of Technology Sleep Laboratory had reported that children ... may need more sleep than others instead of drugs ... is considered an issue of over alertness and nervousness, ... the use of stimulant medications (such as Ritalin) has ...
    ... branded Zidovudine in US has lead to approval of FDA ... and can be imported from other countries. ,Zidovudine ... of AIDS, the drug prevents the replication of the virus ... The drug is also used in combination with other anti-retroviral ...
    ... disease which afflicts hundreds of elderly people may be a ... keep patients mentally agile and slow the crippling illness, say ... and not a normal process of ageing with phases of ... is past, the person slowly goes blank," N.M. Narula, president ...
    ... of the heart may be responsible for causing heart ... State University Dorothy M. Davis Heart and Lung Research ... (RyRs) malfunction in the failing heart. The RyRs form ... prevent the heart from contracting effectively and relaxing adequately. ...
    Cached Medicine News:Health News:Children With ADHD May Just Be Sleepy 2Health News:Active Lifestyle Helps To Slowdown Illness In Alzheimer's Patients 2Health News:Defect In Cardiac Cells Lead To Heart Failures 2
    ... lead family features St. Jude ... The lead is available in ... and silicone (IsoFlex S lead) ... models, and multiple lead lengths, ...
    ... Veriteq's Refrigerator and Freezer Monitoring ... monitoring system for refrigerators and ... install. Using a building's existing ... Freezer monitoring solution automates the ...
    Antiseptic - Antibacterial Sudsing Cleanser...
    HIBICLENS' non-drying, low skin irritation potential promotes compliance with the frequent hand washing associated with today's clinical protocols....
    Medicine Products: